Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Staphylococcus argenteus as an etiological agent of prosthetic hip joint infection: a case presentation
Bo Söderquist1, Peter Wildeman1,2, Bianca Stenmark1
1Department of Laboratory Medicine, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
Abstract:
This report presents a case of prosthetic hip infection caused by Staphylococcus argenteus, a potentially overlooked etiology of prosthetic joint infections (PJIs). Whole-genome sequencing showed that the S. argenteus isolate was an ST2250 and clustered within other CC2250 isolates, the largest clonal group of S. argenteus. This sequence type is prevalent and may be associated with invasive infections. The present isolate was phenotypically fully susceptible to all tested antimicrobial agents and genome analysis did not detect any resistance genes, nor were any staphylococcal cassette chromosome residues detected. Despite initial appropriate management with debridement and biofilm-active antibiotics, the outcome was unfavorable with recurrence and a persistent infection treated with suppressive antibiotics. Regarding the repertoire of genomic traits for virulence in S. argenteus, PJIs caused by this bacterium should be treated accordingly as Staphylococcus aureus PJIs.
Insights
Prosthetic hip infections can be caused by Staphylococcus argenteus, a pathogen often overlooked in prosthetic joint infections (PJIs). This case highlights the need to treat S. argenteus PJIs similarly to Staphylococcus aureus PJIs.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Prosthetic joint infections (PJIs) are a significant complication following joint replacement surgery.
- Staphylococcus aureus is a common cause of PJIs, but other staphylococcal species may also be implicated.
- Staphylococcus argenteus is an emerging pathogen that has been identified in various infections, but its role in PJIs is less understood.
Purpose of the Study:
- To report a case of prosthetic hip infection caused by Staphylococcus argenteus.
- To characterize the isolate using whole-genome sequencing.
- To discuss the clinical implications and treatment strategies for S. argenteus-associated PJIs.
Main Methods:
- Case presentation of a patient with prosthetic hip infection.
- Isolation and identification of the causative pathogen.
- Whole-genome sequencing (WGS) of the Staphylococcus argenteus isolate.
- Antimicrobial susceptibility testing.
- Bioinformatic analysis of WGS data to determine sequence type (ST) and identify virulence factors and resistance genes.
Main Results:
- The prosthetic hip infection was caused by Staphylococcus argenteus.
- Whole-genome sequencing identified the isolate as ST2250, belonging to the largest clonal complex (CC2250) of S. argenteus.
- The isolate was phenotypically susceptible to all tested antibiotics, and WGS did not reveal any antimicrobial resistance genes.
- Despite appropriate initial management including debridement and biofilm-active antibiotics, the patient experienced infection recurrence, necessitating suppressive antibiotic therapy.
Conclusions:
- Staphylococcus argenteus is a potential cause of prosthetic joint infections that may be overlooked.
- The ST2250 strain of S. argenteus may be associated with invasive infections.
- Even in susceptible isolates, S. argenteus PJIs can be challenging to treat, with a risk of recurrence.
- PJIs caused by Staphylococcus argenteus should be managed with the same consideration as those caused by Staphylococcus aureus, given the potential for similar virulence traits.
Related Concept Videos
Endocarditis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management

